These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34063830)

  • 1. Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine.
    Sambon M; Wins P; Bettendorff L
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases.
    Bettendorff L
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels.
    Vignisse J; Sambon M; Gorlova A; Pavlov D; Caron N; Malgrange B; Shevtsova E; Svistunov A; Anthony DC; Markova N; Bazhenova N; Coumans B; Lakaye B; Wins P; Strekalova T; Bettendorff L
    Mol Cell Neurosci; 2017 Jul; 82():126-136. PubMed ID: 28506637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine and benfotiamine protect neuroblastoma cells against paraquat and β-amyloid toxicity by a coenzyme-independent mechanism.
    Sambon M; Napp A; Demelenne A; Vignisse J; Wins P; Fillet M; Bettendorff L
    Heliyon; 2019 May; 5(5):e01710. PubMed ID: 31193162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
    Tapias V; Jainuddin S; Ahuja M; Stack C; Elipenahli C; Vignisse J; Gerges M; Starkova N; Xu H; Starkov AA; Bettendorff L; Hushpulian DM; Smirnova NA; Gazaryan IG; Kaidery NA; Wakade S; Calingasan NY; Thomas B; Gibson GE; Dumont M; Beal MF
    Hum Mol Genet; 2018 Aug; 27(16):2874-2892. PubMed ID: 29860433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dibenzoylthiamine Has Powerful Antioxidant and Anti-Inflammatory Properties in Cultured Cells and in Mouse Models of Stress and Neurodegeneration.
    Sambon M; Gorlova A; Demelenne A; Alhama-Riba J; Coumans B; Lakaye B; Wins P; Fillet M; Anthony DC; Strekalova T; Bettendorff L
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32962139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of benfotiamine and its molecular targets.
    Raj V; Ojha S; Howarth FC; Belur PD; Subramanya SB
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3261-3273. PubMed ID: 29863274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiamine and benfotiamine: Focus on their therapeutic potential.
    Bozic I; Lavrnja I
    Heliyon; 2023 Nov; 9(11):e21839. PubMed ID: 38034619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral benfotiamine reverts cognitive deficit and increase thiamine diphosphate levels in the brain of a rat model of neurodegeneration.
    Moraes RCM; Singulani MP; Gonçalves AC; Portari GV; Torrão ADS
    Exp Gerontol; 2020 Nov; 141():111097. PubMed ID: 32987117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Therapeutic Potential of Benfotiamine in a Sporadic Alzheimer's-Like Disease Rat Model: Insights into Insulin Signaling and Cognitive function.
    Cardinali CAEF; Martins YA; Moraes RCM; Costa AP; Alencar MB; Silber AM; Torrão AS
    ACS Chem Neurosci; 2024 Aug; 15(16):2982-2994. PubMed ID: 39007352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Doses of Thiamine Benefit Patients with the Charcot-Marie-Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes.
    Artiukhov AV; Solovjeva ON; Balashova NV; Sidorova OP; Graf AV; Bunik VI
    Biochemistry (Mosc); 2024 Jul; 89(7):1161-1182. PubMed ID: 39218016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
    Volvert ML; Seyen S; Piette M; Evrard B; Gangolf M; Plumier JC; Bettendorff L
    BMC Pharmacol; 2008 Jun; 8():10. PubMed ID: 18549472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
    Markova N; Bazhenova N; Anthony DC; Vignisse J; Svistunov A; Lesch KP; Bettendorff L; Strekalova T
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():148-156. PubMed ID: 27825907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.
    Bozic I; Savic D; Laketa D; Bjelobaba I; Milenkovic I; Pekovic S; Nedeljkovic N; Lavrnja I
    PLoS One; 2015; 10(2):e0118372. PubMed ID: 25695433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
    Berrone E; Beltramo E; Solimine C; Ape AU; Porta M
    J Biol Chem; 2006 Apr; 281(14):9307-13. PubMed ID: 16452468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
    Beltramo E; Berrone E; Tarallo S; Porta M
    Acta Diabetol; 2008 Sep; 45(3):131-41. PubMed ID: 18581039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
    Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benfotiamine protects against hypothalamic dysfunction in a STZ-induced model of neurodegeneration in rats.
    Moraes RCM; Lima GCA; Cardinali CAEF; Gonçalves AC; Portari GV; Guerra-Shinohara EM; Leboucher A; Donato J; Kleinridders A; Torrão ADS
    Life Sci; 2022 Oct; 306():120841. PubMed ID: 35907494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.